Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Gastroenterology

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/J.GASTRO.2007.05.025PMID 17681167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simple and Effective Determination of Apolipoprotein E Genotypes by Positive/Negative Polymerase Chain Reaction Products

  2006cited by this paper
• Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy.

  2006cited by this paper
• IMPACT OF CYP2C9 GENOTYPE ON PHARMACOKINETICS: ARE ALL CYCLOOXYGENASE INHIBITORS THE SAME?

  2005cited by this paper
• Role of prostaglandins in gastroprotection and gastric adaptation.

  2005cited by this paper
• Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype.

  2005cited by this paper
• Clinical Consequences of Cytochrome P450 2C9 Polymorphisms

  2005cited by this paper
• Upper gastrointestinal symptoms and therapies in elderly out‐patients, users of non‐selective NSAIDs or coxibs

  2005cited by this paper
• Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam

  2005cited by this paper
• Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam in Brazilians

  2005cited by this paper
• Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms

  2004cited by this paper
• Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use

  2004cited by this paper
• Genotyping as a tool to predict adverse drug reactions.

  2004cited by this paper
• CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects.

  2004cited by this paper
• CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers

  2003cited by this paper
• Statistical Methods in Medical Research, 4th edn

  2003cited by this paper
• Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolites.

  2003cited by this paper
• The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal antiinflammatory drugs: The role of gastroprotective drugs

  2003cited by this paper
• Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.

  2002cited by this paper
• Cytochrome P450 pharmacogenetics in drug development: in vitro studies and clinical consequences.

  2002cited by this paper
• Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.

  2002cited by this paper
• An approach to Helicobacter pylori infection in the elderly

  2002cited by this paper
• Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

  2002cited by this paper
• Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

  2001cited by this paper
• Genetic polymorphisms and functional characterization of the 5′‐flanking region of the human CYP2C9 gene: In vitro and in vivo studies

  2001cited by this paper
• Practical Gastrointestinal Endoscopy

  2000cited by this paper
• Genetic Modulation of Oral Anticoagulation with Warfarin

  2000cited by this paper
• CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates.

  2000cited by this paper
• Noninvasive diagnosis of Helicobacter pylori infection in older subjects: comparison of the 13C-urea breath test with serology.

  2000cited by this paper
• Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes.

  1998cited by this paper
• Genetic analysis of the human cytochrome P450 CYP2C9 locus.

  1996cited by this paper
• Bleeding peptic ulcer.

  1994cited by this paper
• Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world

  1992cited by this paper
• CUMULATIVE ILLNESS RATING SCALE

  1968cited by this paper

• Global Burden of Peptic Ulcer Disease in Adolescents and Young Adults: Trends and Disparities from 1990-2021.

  2025cites this paper
• Peptic Ulcers: Understanding Etiology, Pathophysiology, Diagnosis, Treatment of Peptic Ulcers

  2025cites this paper
• Pharmacogenetics polygenic response score predicts outcomes in aspirin-treated stroke patients

  2025cites this paper
• Genetic Mutations and Small Bowel Ulcerating Disease: Role in Diagnosis?

  2025influential citation
• Mechanisms of pain in aging and age-related conditions: focus on caregivers.

  2024cites this paper
• Association of CYP2C9∗3 and CYP2C8∗3 Non-Functional Alleles with Ibuprofen-Induced Upper Gastrointestinal Toxicity in a Saudi Patient

  2023cites this paper
• Healthcare Disparities and Upper Gastrointestinal Bleeding: Exploring the Linkages

  2023cites this paper
• Peptic Ulcer Disease.

  2023cites this paper
• Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

  2023cites this paper
• Pharmacogenetic predictors of the safety of nonsteroidal anti-inflammatory drugs

  2023cites this paper
• The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: A full case-control study

  2023cites this paper
• Clinical Efficacy, Pharmacokinetics, and Safety of the Available Medical Options in the Treatment of Endometriosis-Related Pelvic Pain: A Scoping Review

  2023cites this paper
• Effect of CYP2C9, PTGS-1 and PTGS-2 gene polymorphisms on the efficiency and safety of postoperative analgesia with ketoprofen

  2022cites this paper
• Structure of the distribution of genetic determinants of the efficacy and safety of non-steroidal anti-inflammatory drugs in the Russian population: focus on CYP2C8, PTGS1 and PTGS2

  2022cites this paper
• Opioid-Related Genetic Polymorphisms of Cytochrome P450 Enzymes after Total Joint Arthroplasty: A Focus on Drug-Drug-Gene Interaction with Commonly Coprescribed Medications.

  2022cites this paper
• Polygenic Pharmacogenetic Score Forecasts Outcomes in Stroke Patients Receiving Aspirin Therapy

  2022cites this paper
• Integrated Metabolomics and Network Pharmacology to Decipher the Latent Mechanisms of Protopanaxatriol against Acetic Acid-Induced Gastric Ulcer

  2022cites this paper
• [Evaluation of the association of polymorphisms of the CYP2C8 gene with the efficacy and safety of ketorolac in patients with postoperative pain syndrome].

  2022cites this paper
• Denisenko N.P.1, Abdullaev Sh.P.1, Akmalova K.A.1, Sozaeva Zh.A.1, Kachanova A.A.1, Sozaeva M.S-Kh.2, Bolieva L.Z.3, Grishina E.A.1, Sychev D.A.1

  2022cites this paper
• EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING SECONDARY TO PEPTIC DISEASE IN A TERTIARY REFERRAL BRAZILIAN HOSPITAL.

  2021cites this paper
• A novel gene associated with small bowel bleeding in patients taking low-dose aspirin.

  2021cites this paper
• Applying Pharmacogenomic Guidelines to Combat Medical Care.

  2021cites this paper
• Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration

  2021cites this paper
• Genetic variations and epigenetic modulations in CYP genes: Implications in NSAID-treatment of arthritis patients

  2021cites this paper
• Evaluation of the Influence of CYP2C9* 2, CYP2C9*3 Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery

  2021cites this paper
• Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity

  2021cites this paper
• PRINCIPAL ASPECTS OF PATHOGENESIS OF CHRONIC VIRAL HEPATITIS IN UZBEKISTAN

  2020cites this paper
• An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding

  2020influential citation
• Importancia de la genética en la osteoartrosis

  2020cites this paper
• Assessment of the impact of PTGS1, PTGS2 and CYP2C9 polymorphisms on pain, effectiveness and safety of NSAID therapies

  2020cites this paper
• Can Implementation of Genetics and Pharmacogenomics Improve Treatment of Chronic Low Back Pain?

  2020cites this paper
• Comparison of CYP2C9 Activity in Ethiopian and Non-Ethiopian Jews Using Phenytoin as a Probe

  2020cites this paper
• Genetic polymorphisms associated with upper gastrointestinal bleeding: a systematic review

  2020cites this paper
• Major CYP450 polymorphism Among Saudi Patients.

  2020cites this paper
• Association between CYP2C9 polymorphisms and ischemic stroke following endovascular neurointervention.

  2020cites this paper
• Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs

  2020cites this paper
• Effect of Ketoprofen and ATB-352 on the Immature Human Intestine: Identification of Responders and Non-responders

  2019cites this paper
• CYP2D6 Pharmacogenetics Testing and Post–Cesarean Section Pain Scores—a Preliminary Study

  2019cites this paper
• Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases

  2019cites this paper
• Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline

  2019cites this paper
• AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers – a pilot study in healthy volunteers

  2019cites this paper
• Pharmacogenomics in Palliative Medicine

  2019cites this paper
• Pharmacogenetics of non-steroidal anti-inflammatory drugs: existing problems for clinical practice

  2019cites this paper
• Pharmacogenetics of non-steroidal anti-inflammatory drugs : EXISTING PROBLEMS FOR CLINICAL PRACTICE

  2019cites this paper
• Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer

  2019cites this paper
• Pharmacogenomics of analgesics in anesthesia practice: A current update of literature

  2018cites this paper
• Genetics of perioperative pain management

  2018cites this paper
• Pharmacogenomics Testing for Postoperative Pain Optimization Before Total Knee and Total Hip Arthroplasty.

  2018cites this paper
• Bactericidal/Permeability-Increasing Fold-Containing Family B Member 4 May Be Associated with NSAID-Induced Enteropathy

  2018cites this paper
• Pharmacogenomics, precision medicine, and implications for anesthesia care.

  2018cites this paper
• Gender, genetics, and analgesia: understanding the differences in response to pain relief

  2018cites this paper
• Pharmacogenomics of CYP2C9: Functional and Clinical Considerations†

  2017cites this paper
• Nonsteroidal Anti-inflammatory Drug (NSAID) adalah golongan obat pereda nyeri yang paling banyak diresepkan dan digunakan di dunia. Meskipun banyak digunakan tetapi NSAID tidak lepas dari efek samping. Efek samping serius yang paling sering terjadi adalah pendarahan pada saluran gastrointestinal. Be

  2017cites this paper
• Towards better models and mechanistic biomarkers for drug‐induced gastrointestinal injury

  2017cites this paper
• Review article: a practical approach to the clinical management of NSAID enteropathy

  2017cites this paper
• Celecoxib-induced Liver Injury: Analysis of Published Case Reports and Cases Reported to the Food and Drug Administration

  2017cites this paper
• Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.

  2017cites this paper
• Pharmacogenetics-guided analgesics in major abdominal surgery: Further benefits within an enhanced recovery protocol.

  2017cites this paper
• The genetics of gout: towards personalised medicine?

  2017cites this paper
• TERATOGENESIS OF ANTIEPILEPTIC DRUGS: REVIEW AND CLINICAL CASES

  2016cites this paper
• Efficacy and Safety of Long-Term Administration of Tapentadol in Relieving Chronic Pancreatitis Pain.

  2016cites this paper
• How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity / Kako polimorfizmi gena citokroma P450 utječu na metabolizam i toksičnost ibuprofena i diklofenaka

  2016cites this paper
• Study of Clinical and Genetic Risk Factors for Aspirin-induced Gastric Mucosal Injury

  2016cites this paper
• Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?

  2016cites this paper
• Future Perspectives in Drug Therapy of Older Adults

  2016cites this paper
• Pharmacogenomics of non-steroidal antiinflammatory drug-induced gastrointestinal complications

  2016cites this paper
• The pharmacogenomics of pain management: prospects for personalized medicine

  2016cites this paper
• CYPC19*17 POLYMORPHISM AS A RISK-FACTOR FOR NSAIDS-INDUCED ULCERS

  2016cites this paper
• CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case–control study

  2016cites this paper
• Gr upSM Etiology of Peptic Ulcer Disease

  2016cites this paper
• Systematic characterization and comparison of the CYP2C9 variability of the Orang Asli in Malaysia with 12 populations.

  2016cites this paper
• AGT A-20 C ( rs 5050 ) gene polymorphism and ulcer occurrence in patients treated with low-dose aspirin : a case-control study

  2015cites this paper
• AGT A-20C (rs5050) gene polymorphism and ulcer occurrence in patients treated with low-dose aspirin: a case-control study / Polimorfismul AGT A-20C și ulcerele gastro-duodenale la pacienții sub tratament cu aspirină în doze antiagregante: studiu caz-control

  2015cites this paper
• To translate pharmacogenetics in geriatrics: towards a personalized medicine

  2015cites this paper
• PharmGKB summary: ibuprofen pathways

  2015cites this paper
• Pharmacogenetic considerations in the treatment of gout.

  2015cites this paper
• Gastrointestinal Adverse Reactions from Ibuprofen

  2015cites this paper
• Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro

  2015cites this paper
• Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management

  2015cites this paper
• Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.

  2015cites this paper
• Low-Dose Aspirin-Associated Upper and Mid Gastrointestinal Tract Damage and Gene Polymorphism.

  2015cites this paper
• Novel Use of Pharmacogenetic Testing in the Identification of CYP2C9 Polymorphisms Related to NSAID-Induced Gastropathy.

  2015cites this paper
• Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain Treatment.

  2015cites this paper
• Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers

  2015cites this paper
• Celecoxib for the Right Person at the Right Dose and Right Time: An Updated Overview

  2015cites this paper
• Pharmacodynamics- and Pharmacogenetics-Guided Antiplatelet Therapy

  2014cites this paper
• Pharmacogenetics of chronic pain management.

  2014cites this paper
• Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding.

  2014cites this paper
• CYP2C9 Allelic Variants and Frequencies in a Pediatric Sickle Cell Disease Cohort: Implications for NSAIDs Pharmacotherapy

  2014cites this paper
• Safety of anti-tumor necrosis factor therapies in arthritis patients.

  2014cites this paper
• Cytochrome P450 interactions and clinical implication in rheumatology

  2014cites this paper
• Drug Response Heterogeneity and the Genetic Variability of Cytochrome P450–Metabolizing Enzymes

  2014cites this paper
• Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives.

  2014cites this paper
• Risk factors of symptomatic NSAID‐induced small intestinal injury and diaphragm disease

  2014cites this paper
• Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights.

  2014cites this paper
• 11 – An Introduction to Pharmacogenetics in Pain Management: Knowledge of How Pharmacogenomics May Affect Clinical Care

  2014cites this paper
• Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review.

  2014cites this paper
• Applications of CYP450 Testing in the Clinical Setting

  2013cites this paper
• A Brief Guide to Pharmacogenetics in Pain Management

  2013cites this paper
• Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

  2013cites this paper